Skip to main content
OpenTrials

Clinical trial condition

Factor 8 deficiency, acquired

Explore clinical trials studying Factor 8 deficiency, acquired. Study availability and eligibility vary by location and protocol.

11 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Factor 8 deficiency, acquired trial results

Recruiting

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

NCT06727669

Conditions
Arterial Thromboembolism, Autoimmune Diseases, Bleeding Disorder, +45 more
Locations
  • Peking University Insititute of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China
  • Department of Hematology, Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Department of Hematology, Beijing Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Active, not recruiting

Emicizumab in Patients With Acquired Hemophilia A

NCT05345197

Conditions
Acquired Hemophilia A, Factor 8 deficiency, acquired
Locations
  • UCSD Hemophilia and Thrombosis Treatment Center San Diego, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
View all 16 locations
View Trial Details
Completed

Study of TAK-672 in Participants With Acquired Hemophilia A

NCT04580407

Conditions
Acquired Hemophilia A, Factor 8 deficiency, acquired
Locations
  • Gunma University Hospital Maebashi, Gunma, Japan
  • Nagoya University Hospital Aichi, Nagoya, Japan
  • Nara Medical University Hospital Kashihara-shi, Nara, Japan
  • Uonuma Kikan Hospital Minamiuonuma, Niigata, Japan
View Trial Details
Completed

Emicizumab in Acquired Hemophilia A

NCT04188639

Conditions
Factor 8 deficiency, acquired, Hemophilia A, Acquired
Locations
  • Medizinische Universität Wien, Hämatologie/Hämostaseologie Wien, Lower Austria, Austria
  • Medizinische Universitätsklinik Graz Graz, Styria, Austria
  • Landeskrankenhaus Salzburg, Universitätsklinikum der PMU, Innere Med. III Salzburg, Austria
  • LMU Klinikum, Hämophiliezentrum Erwachsene/Transfusionsmedizin München, Bavaria, Germany
View all 16 locations
View Trial Details
Completed

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

NCT03199794

Conditions
Acquired Hemophilia A, Factor 8 deficiency, acquired
Locations
  • University of Florida - Shands Gainesville, Florida, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View all 26 locations
View Trial Details
Completed

Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A

NCT02610127

Conditions
Acquired Hemophilia A, Factor 8 deficiency, acquired
Locations
  • University of Colorado Health Aurora, Colorado, United States
  • University of Florida Gainesville, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
View all 16 locations
View Trial Details

Related conditions